Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Retraction Notice: Comprehensive Evaluation of Serum Microbiota and Metabolomic Profiles in Osteoporosis Patients Utilizing 16S rDNA Sequencing and UHPLC/MS Techniques

  • July 16, 2026

Share

Clinical Scorecard: Retraction Notice: Comprehensive Evaluation of Serum Microbiota and Metabolomic Profiles in Osteoporosis Patients Utilizing 16S rDNA Sequencing and UHPLC/MS Techniques

At a Glance

CategoryDetail
ConditionOsteoporosis
Key MechanismsSerum microbiota and metabolomic profiles
Target PopulationPatients with osteoporosis
Care SettingResearch integrity and data validation

Key Highlights

  • The article was retracted due to concerns about data validity.
  • Authors failed to provide raw data during the investigation.
  • Retraction approved by the Chief Editors of Frontiers in Medicine.
  • No response from authors regarding the retraction.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Osteoporosis patients

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics

            • July 16, 2026

            Related Content

            Explainable machine learning for osteoporosis detection in patients with osteopenia: model development and validation using routine clinical data from an Asian cohort

            Medical Oddities: Natural Doesn't Always Mean Safe

            From the gym to the kitchen to romance, these studies challenge everyday assumptions.

            Osteoimmuno-brain axis: a bridge connecting osteoporosis and cognitive decline and its clinical significance in dementia and Alzheimer’s disease